(ORMP) Oramed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Oramed Pharmaceuticals | (ORMP) share price targets
Complete technical analysis of Oramed Pharmaceuticals (ORMP) by charts plus indicators, forecast predictions and share price targets for Oramed Pharmaceuticals (ORMP)
Oramed Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-25 View latest technical analysis
10 day averaged volume of Oramed Pharmaceuticals is 131500
Date | Daily Closing Price | Open | High | Low | Volume |
25 Mon Nov 2024 | 2.35 | 2.35 | 2.38 | 2.33 | 1.3 times |
22 Fri Nov 2024 | 2.34 | 2.31 | 2.39 | 2.30 | 0.813 times |
21 Thu Nov 2024 | 2.31 | 2.27 | 2.36 | 2.27 | 0.958 times |
20 Wed Nov 2024 | 2.26 | 2.27 | 2.30 | 2.26 | 0.463 times |
19 Tue Nov 2024 | 2.30 | 2.18 | 2.31 | 2.18 | 0.821 times |
18 Mon Nov 2024 | 2.17 | 2.25 | 2.30 | 2.13 | 1.808 times |
15 Fri Nov 2024 | 2.23 | 2.33 | 2.33 | 2.22 | 0.837 times |
14 Thu Nov 2024 | 2.34 | 2.31 | 2.37 | 2.31 | 0.796 times |
13 Wed Nov 2024 | 2.32 | 2.32 | 2.35 | 2.31 | 0.573 times |
12 Tue Nov 2024 | 2.34 | 2.29 | 2.35 | 2.27 | 1.097 times |
My analysis of stock is bullish for shortterm, and stock might move up till 2.4 or till 2.4. Use a stoploss of 2.32 and if this stock hits its stoploss, then it can fall down till 2.27
Share price targets for Oramed Pharmaceuticals (ORMP)
Target Type | Value |
Downside Target | 2.10 |
Downside Target | 2.22 |
Downside Target | 2.33 |
Upside Target | 2.41 |
Upside Target | 2.42 |
Upside Target | 2.43 |
Upside Target | 2.46 |
Upside Target | 2.57 |
Upside Target | 2.67 |
Upside Target | 2.75 |
Intraday share price targets for Oramed Pharmaceuticals (ORMP)
Target Type | Value |
Downside Intraday Target | 2.33 |
Downside Intraday Target | 2.3 |
Upside Intraday Target | 2.38 |
Upside Intraday Target | 2.4 |
Upside Intraday Target | 2.35 |
Weekly technical analysis of Oramed Pharmaceuticals (ORMP)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Mon Nov 2024 | 2.35 | 2.35 | 2.38 | 2.33 | 0.267 times |
22 Fri Nov 2024 | 2.34 | 2.25 | 2.39 | 2.13 | 0.947 times |
15 Fri Nov 2024 | 2.23 | 2.31 | 2.42 | 2.22 | 1.187 times |
08 Fri Nov 2024 | 2.31 | 2.33 | 2.43 | 2.27 | 1.276 times |
01 Fri Nov 2024 | 2.32 | 2.36 | 2.41 | 2.25 | 1.601 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Oramed Pharmaceuticals (ORMP)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Mon Nov 2024 | 2.35 | 2.37 | 2.43 | 2.13 | 1.165 times |
31 Thu Oct 2024 | 2.38 | 2.42 | 2.46 | 2.25 | 0.898 times |
30 Mon Sep 2024 | 2.44 | 2.38 | 2.75 | 2.28 | 0.736 times |
30 Fri Aug 2024 | 2.39 | 2.46 | 2.57 | 2.10 | 1.397 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Oramed Pharmaceuticals (ORMP)
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Oramed Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Oramed Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Oramed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Oramed Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.29 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Oramed Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Oramed Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Oramed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Oramed Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.29 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.